Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Mani Vannan
The session focused on the need for adequate training to obtain the necessary level of Doppler Tissue Imaging as a method to accurately and reproducibly measure mechanical dyssynchrony.
Dr Mani Vannan’s presentation provided some insights into a “newer” approach where mechanical dis-coordination of the entire left ventricle measured automatically from a volume (echo) data, similar to CURE index by CMR, may potentially be an imaging-based target to predict response/no-response to CRT. The role of venous anatomy and myocardial scar burden in determining the success of CRT was reviewed by Dr Nico Van de Veire. Dr Martin St. John Sutton presented emerging data from clinical studies supporting the expanding use of CRT in mild-moderate HF. Dr John Gorcsan then presented a comprehensive review of the data, new and old, which highlighted the role of mechanical dyssynchrony measured by echocardiography as an emerging predictor of outcome in the HF population with and without CRT.
The content of the session was comprehensive. A panel discussion to tease out what is the current role of imaging practice and the controversies underlying what we measure added to the value of the session. Given that CRT has become “standard” device therapy and the costs associated with it are considerable, imaging may in fact aid in optimal selection (over and above the clinical/EKG profile) to enhance the outcomes. This latter issue has been extensively talked and written about, but it needs a meaningful clarification of the everyday practitioner. An expert panel discussion with “real-life” case presentations would be helpful.
Is echo still useful for resynchronisation therapy?
© 2017 European Society of Cardiology. All rights reserved